Paragon 28, Inc. (FNA)
NYSE: FNA · IEX Real-Time Price · USD
9.77
0.00 (0.00%)
At close: May 3, 2024, 4:00 PM
10.50
+0.73 (7.47%)
After-hours: May 3, 2024, 7:48 PM EDT
Paragon 28 Revenue
In the year 2023, Paragon 28 had annual revenue of $216.39M with 19.30% growth. Revenue in the quarter ending December 31, 2023 was $60.56M with 17.58% year-over-year growth.
Revenue (ttm)
$216.39M
Revenue Growth
+19.30%
P/S Ratio
4.03
Revenue / Employee
$376,984
Employees
574
Market Cap
872.27M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 216.39M | 35.01M | 19.30% |
Dec 31, 2022 | 181.38M | 33.92M | 23.00% |
Dec 31, 2021 | 147.46M | 36.48M | 32.87% |
Dec 31, 2020 | 110.98M | 4.70M | 4.42% |
Dec 31, 2019 | 106.28M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Definitive Healthcare | 251.42M |
Evolus | 202.09M |
National Research | 148.58M |
REGENXBIO | 90.24M |
Mesoblast | 7.25M |
Pliant Therapeutics | 1.58M |
FNA News
- 3 days ago - Paragon 28 to Present at the Bank of America Securities 2024 Healthcare Conference - Business Wire
- 4 weeks ago - Appointment of Stephen M. Deitsch as new Chief Financial Officer - GlobeNewsWire
- 4 weeks ago - NeuroStreet To Transform Trading Technology With Tickblaze Acquisition - Business Wire
- 4 weeks ago - Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024 - Business Wire
- 5 weeks ago - Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System - Business Wire
- 2 months ago - Paragon 28 Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Net Revenue Guidance - Business Wire
- 2 months ago - Paragon 28 to Present at the CG 2024 Musculoskeletal Conference - Business Wire
- 3 months ago - Paragon 28 To Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024 - Business Wire